Cargando…
Five-year evolution of drug prescribing in a university adult intensive care unit
Autores principales: | Voirol, P, Eggimann, P, Carron, C, Pannatier, A, Chiolero, R, Wasserfallen, JB |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934347/ http://dx.doi.org/10.1186/cc8705 |
Ejemplares similares
-
Guidelines-associated decrease in mortality with recombinant activated factor VII for refractory hemorrhage
por: Schneider, AS, et al.
Publicado: (2009) -
Risk factors for hypertriglyceridemia in the intensive care unit: an exploratory study
por: Devaud, JC, et al.
Publicado: (2010) -
Safety of activated recombinant factor VII in patients with circulatory assist devices
por: Schneider, AS, et al.
Publicado: (2009) -
Antibiotics’ consumption to early detect epidemics of P. aeruginosa in a burn center: a paradigm shift in the epidemiological surveillance of nosocomial infections
por: Fournier, A, et al.
Publicado: (2015) -
Haemodynamic effects of a fluid challenge with hydroxylethyl starch 130/0.4 (Voluven(®)) in patients suffering from symptomatic vasospasm after subarachnoid haemorrhage
por: Van Tulder, L, et al.
Publicado: (2008)